Gaining Insights Into Disease Biology for Target Identification and Validation Using Seahorse XF Technology
Application Note Dec 20, 2019
It is now well accepted that dysfunctional metabolism is associated with many different disease states, including cancer, immunological disorders, neurodegeneration, diabetes, and obesity. Therefore, looking at the genes, proteins, and pathways that modulate metabolism is a promising avenue for developing novel therapeutic targets for a broad range of diseases.
Agilent Seahorse XF technology measures energy metabolism in live cells, providing critical information that relates directly to cellular function.
Download this application note to discover how the Seahorse XF assay can be used to predict:
- Cancer cell vulnerabilities
- Immune cell fate and function
- Neuronal cell health